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AbstrACt
Objective There is a growing need for researchers 
to demonstrate impact, which is reliant on successful 
research translation. The Australian National Health 
and Medical Research Council funded a Centre of 
Research Excellence in Stroke Rehabilitation and Brain 
Recovery (CRE-Stroke) to enhance collaborations 
between researchers conducting different types of stroke 
rehabilitation research. The purpose of this study was to 
explore opinions about research translation held by CRE-
Stroke researchers conducting preclinical and clinical 
research, in terms of scope, importance, responsibility and 
perceived skills and knowledge.
Design Mixed-methods study, comprising a paper-based 
survey and semistructured interviews. Interview data were 
inductively coded and thematically analysed. Survey and 
interview data were compared and synthesised.
Participants 55 (7 preclinical, 48 clinical) researchers 
attending a CRE-Stroke research forum completed a 
paper-based survey. Semistructured interviews with 22 
CRE-Stroke (5 preclinical, 17 clinical) researchers were 
conducted.
results Research translation was described as translating 
to other research and translating to clinical practice 
and policy. Most researchers (n=54, 98%) reported that 
research translation was important, particularly in terms 
of generating research impact, but the most common sign 
of project completion reported by researchers (n=7, 100% 
preclinical; n=37, 77% clinical) was publication. Most 
researchers (preclinical n=4, 57%; clinical n=37, 77%) 
reported having responsibility for translating research, but 
less than half reported having the necessary skills (n=1, 
14% preclinical; n=17, 35% clinical) and knowledge (n=3, 
43% preclinical; n=19, 40% clinical). Differing opinions 
about who should be responsible for translating findings to 
clinical practice were expressed.
Conclusions Stroke rehabilitation researchers appear 
confident to translate their research via the traditional 
mechanism of publications. To optimise impact, clarity 
is needed regarding who is best placed to translate 
research findings to clinical practice and policy. 
Education and skills development to apply broader 
translation processes are needed to maximise the use of 
research at all stages.
IntrODuCtIOn 
Internationally, there is a growing need 
to demonstrate research impact, with 
Australia and the UK recently including 
research impact in university performance 
metrics.1 2 Research impact is dependent on 
research translation.3 We define research 
translation as adapting research findings for 
application in a different context or for use 
by a different group. Our definition encom-
passes bench-to-bedside translation (trans-
lating basic biomedical research into clinical 
science and knowledge)4 and research-to-
practice translation (synthesising and 
applying knowledge from clinical research to 
healthcare services and systems).5 Research-
to-practice translation encompasses diffusion 
(passive release of information), dissemina-
tion (tailoring and delivering the evidence to 
target audiences) and implementation (iden-
tifying and overcoming barriers to assist the 
target audience to apply the evidence).6 
The Australian National Health and Medical 
Research Council funded the Centre of 
Research Excellence in Stroke Rehabilitation 
and Brain Recovery (CRE-Stroke) from 2015 
to 2019 to enhance collaborations between 
researchers from diverse backgrounds to 
accelerate the development, translation and 
implementation of new stroke rehabilitation 
strengths and limitations of this study
 ► Participants were from one of the largest global 
stroke rehabilitation research centres, conducting 
research from basic science to clinical trials to pop-
ulation health.
 ► Small proportion of preclinical researchers com-
pared with clinical researchers, reflecting profile of 
researchers involved in CRE-Stroke.
 ► Responses of participants may have been influenced 
by authors’ involvement in CRE-Stroke.
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and recovery interventions and techniques.7 CRE-Stroke 
is one of the largest stroke research centres globally, 
coordinated by The Florey Institute of Neuroscience 
and Mental Health (the Florey) and Hunter Medical 
Research Institute (HMRI), formally involving 86 (20 
senior) researchers and clinicians and a broad network 
of affiliated members. The five nominated research 
streams within CRE-Stroke are Basic Science, Imaging 
Discovery, Clinical Trials, Implementation Science and 
Data Linkage.
It has been argued that translation of knowledge from 
preclinical research is fundamentally different from 
translation of knowledge arising from clinical research 
in terms of goals, skills required, individuals involved 
and the complexity of the environment.8 Survey data 
from one study indicated that preclinical researchers 
were more likely than clinical researchers to join teams 
specifically designed to enhance research translation.9 
However, little is known about whether preclinical and 
clinical researchers perceive research translation differ-
ently in terms of importance and responsibility. The 
aim of this study was to explore opinions about research 
translation held by CRE-Stroke researchers and to iden-
tify the similarities and differences expressed by preclin-
ical researchers (working in Basic Science and Imaging 
Discovery streams) and clinical researchers (Clinical 
Trials, Implementation Science, Data Linkage). Findings 
would inform strategy development to enhance research 
translation and subsequent research impact activities. 
Our specific research questions were:
 ► How do researchers describe research translation?
 ► How important is research translation?
 ► Who do researchers feel should be responsible for 
research translation?
 ► Do researchers believe they have the knowledge and 
skills to translate their research?
MethODs
A mixed-methods (explanatory sequential) design was 
used, where qualitative data from semistructured inter-
views were used to explain and interpret quantitative 
data from a survey.10 Ethical approval to conduct the 
study was obtained from the University of Melbourne (ID 
1647818.2).
Data collection
In September 2016, attending researchers at a Florey 
Rehabilitation Workshop and Annual Scientific Meeting 
were invited to complete a paper-based survey. The survey 
(online supplementary appendix A) was developed specif-
ically for this study and was piloted on three researchers 
not involved in stroke research. Demographic data were 
collected, and statements about research translation with 
predefined tick box responses (2 statements) or a 5-point 
Likert scale of agreement (11 statements) were included. 
Completion of the survey implied consent.
Between November and December 2016, 22 interviews 
were conducted with purposively selected researchers to 
represent the breadth of CRE-Stroke research activity. 
When multiple researchers worked on similar projects, 
the most senior researcher was invited to participate. 
Twenty-seven researchers were invited by email to partic-
ipate; five (four preclinical and one clinical) researchers 
declined due to being on maternity leave (n=2), unable 
to schedule interview (n=2) or no longer involved in 
CRE-Stroke (n=1). The interview guide (online supple-
mentary appendix B) was designed to seek more detailed 
information about aspects of interest from the survey. 
Participants were given information sheets and signed 
consent forms prior to interviews. Two authors (EAL and 
SAR who were employed as research fellows in Imple-
mentation Science in CRE-Stroke and Health Research 
Economics at HMRI, respectively) conducted the inter-
views at the Florey in Melbourne, Victoria and at HMRI 
in Newcastle, New South Wales. Nineteen interviews 
were conducted in person and three over the phone as 
per participants’ preferences and availability. All authors 
were known to interviewees at the time of the interviews 
through their mutual affiliations with CRE-Stroke, so only 
authors EAL and SAR had access to full interview tran-
scripts. Interviews lasted between 30 and 60 min, were 
audio recorded, transcribed by a third party and checked 
by the interviewers and participants for accuracy. No 
repeat interviews were conducted.
Data analysis
Survey data
Responses from the 5-point Likert scale questions were 
collapsed into two categories. Positive statements were 
categorised as affirmative (strongly agree, agree) or 
not affirmative (neither agree nor disagree, disagree or 
strongly disagree). Responses to the negative statement 
‘My research cannot be translated’ were categorised 
as negative to research translation (neither agree nor 
disagree, agree, strongly agree) or not negative to research 
translation (strongly disagree or disagree).
Data analysis of quantitative variables was performed in 
SPSS Statistics 21.0.11 Frequencies statistics are presented, 
and χ2 tests were used to compare the proportion of 
affirmative responses to the survey statements given by 
preclinical and clinical researchers.
Interview data
Deidentified transcripts were imported into NVivo 
11.12 Participants were grouped as preclinical and clin-
ical researchers. Data were broadly mapped to the four 
research questions.
Using inductive thematic analysis as described by Braun 
and Clark,13 authors EAL and SAR mapped data from 
each of the research questions to codes and categories. 
The two coders analysed three transcripts independently 
before checking consistency of methods and discussing 
the thematic coding systems. The coders then inde-
pendently examined and coded a fourth transcript. At 
this point, there was consistency between coders, so EAL 
coded the remaining transcripts and regularly discussed 
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the coding and the development of themes with SAR 
who was present at all interviews and had read each tran-
script. Themes arising from preclinical researchers were 
compared with those arising from clinical researchers.
synthesis of data from two sources
Data from the survey and interviews were compared for 
each of the research questions in a side-by-side compar-
ison, to allow a further analysis through comparing 
consistency and meaning of responses. This is presented 
in online supplementary table 1.
Patient involvement
Patients were not involved in the design of this study.
results
Fifty-seven researchers completed the survey and 22 
researchers were interviewed (14 had also completed 
the survey). Two survey respondents were not currently 
involved in research, so their data were excluded from 
analysis. Most survey respondents (n=48, 87%) were 
involved in clinical or health services research, just over 
half were women (n=32, 58%) and were enrolled in or 
had completed their PhD within the previous 5 years 
(n=28, 51%). Similarly, most interview participants 
(n=17, 77%) were involved in clinical research, most were 
women (n=15, 68%) but there was a higher proportion 
of mid-career or senior-career researchers involved in the 
interviews (n=13, 59% completed PhD 5 or more years 
previously). Demographic details of survey participants 
are presented in table 1. Further demographic details of 
the interview participants are not presented to preserve 
participant anonymity.
Survey responses from preclinical (n=7) and clinical 
(n=48) researchers are presented in table 2. A signifi-
cantly higher proportion of clinical researchers reported 
measuring research impact in terms of incorporation into 
clinical guidelines, and numbers of clinicians using their 
research. There was no significant difference in propor-
tions of preclinical and clinical researchers who agreed 
with the included statements regarding importance of, 
responsibility for and skills and knowledge in research 
translation, with one exception: one preclinical (14% 
of sample) and no clinical researchers disagreed with 
the statement ‘It is important to me that my research is 
translated’.
Perceptions about the scope of research translation
In interviews, two types of research translation were 
described: translating research findings to other research 
projects and translating research findings to clinical prac-
tice or policy.
translating to other research projects
Preclinical and clinical researchers described translating 
research between animal models and human models:
We have now very solid animal data proving … that 
[factor] is detrimental. And we also studied the 
mechanisms of [factor] at a cellular level and we have 
found … that [factor] is very closely connected to … 
secondary neurodegeneration … I would like us to 
consider having [factor] monitoring for the stroke 
recovery and the stroke rehab programs to under-
stand each individual’s [factor] level and try to coun-
teract that [PreClinical_1].
In the [literature] review of animal models of stroke, 
we found that [intervention] was effective in improv-
ing … function … and based on that, we then said, 
Well we’ve got to translate this into a clinical setting. 
What is a feasible model? [Clinical_1].
Preclinical researchers described translation in terms 
of collaborations with clinical researchers, whereby newly 
developed laboratory or imaging techniques provided 
physiological data associated with the symptoms of stroke.
Once we get the tools and technologies … I would 
like to go and work with [clinical researchers] and 
Table 1 Demographic details of participants and responses 
to survey questions
Demographic and other participant 
variables
n 
(N=55) %
Professional background
  Physiotherapy/occupational therapy/
speech pathology/exercise physiology
21 38
  Science 13 24
  Medicine 8 15
  Nursing 3 5
  Psychology 3 5
  Other (health): paramedicine, pharmacy, 
social work, exercise science
4 7
  Other (non-health): engineering, social 
science, statistics
3 5
When was PhD completed
  Currently enrolled 17 31
  Within last 5 years 11 20
  >5–10 years 8 15
  >10–15 years 5 9
  >15–20 years 2 4
  >20 years 5 9
  Not completed, not enrolled 7 13
Sex
  Male 23 42
  Female 32 58
Main focus of research
  Clinical/qualitative stroke research 39 71
  Basic science 7 13
  Health services research 9 16
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say, I think that there’s an innovative way that you 
can look … at [factor] in your patients using say, a 
spot of blood … It will tell you this is your [physio-
logical] status, or their risk of developing [symptom] 
[PreClinical_2].
Both preclinical and clinical researchers described 
translating research to develop a clinical intervention 
more rigorously.
[Clinical researchers] need to get talking to [pre-clin-
ical researchers] … When you’re talking … stroke 
rehab … we have no idea about the mechanisms of 
why these things work … we have to come back to 
that basic science … to try and understand why … 
things might work to inform better development of 
interventions [Clinical_2].
translating research to clinical practice and policy
Most clinical researchers and several preclinical 
researchers described research translation in terms 
of changing clinical practice and clinical researchers 
Table 2 Agreement with survey statements regarding research translation
Preclinical, n (%)
n=7
Clinical, n (%)
n=48 χ2 test (p value)
I consider each research project complete when:*
  Results are presented in publication 7 (100) 37 (77.1) 2.01 (0.16)
  Findings have been incorporated into policy/practice 3 (42.9) 31 (64.6) 1.22 (0.27)
  Findings have led to new trials 3 (42.9) 22 (45.8) 0.02 (0.88)
  Data analysis is complete 4 (57.1) 11 (22.9) 3.61 (0.06)
  Funding for trial is spent 1 (14.3) 4 (8.3) 0.26 (0.61)
  Other (may be dormant, never really complete, depends on research 
aim)
0 (0) 3 (6.3) 0.46 (0.50)
I measure the impact of my research by:*
  Incorporation into clinical guidelines 2 (28.6) 42 (87.5) 13.3 (0.00)
  Number of clinicians using my research 3 (42.9) 39 (81.3) 4.99 (0.03)
  Number academic publications 6 (85.7) 35 (72.9) 0.53 (0.47)
  Citations 7 (100) 33 (68.8) 3.01 (0.08)
  Incorporation into policy 4 (57.1) 25 (52.1) 0.06 (0.80)
  Awards or grants 4 (57.1) 22 (45.8) 0.31 (0.58)
  Social and electronic media presence 2 (28.6) 15 (31.3) 0.02 (0.89)
  Other (downloads, improved outcomes for stroke survivors, findings 
incorporated into routine use by consumers/clinicians, development of 
sustainable business model to support developed technologies)
1 (14.3) 4 (8.3) 0.26 (0.61)
Agreement (strongly agree/agree) with statements
  It is important to me that my research is translated 6 (85.7) 48 (100) 6.98 (0.01)
  My research is not the sort of research that can be translated† 1 (14.3) 6 (12.5) 0.02 (0.90)
  It is my responsibility to ensure my research is translated 4 (57.1) 37 (77.1) 1.28 (0.26)
  Research translation is the responsibility of someone else in my team 2 (28.6) 16 (33.3) 0.06 (0.80)
  Clinicians should be responsible for translating findings into clinical 
practice
2 (28.6) 32 (66.7) 3.76 (0.05)
  I know which strategies should be used to translate my research 3 (42.9) 19 (39.6) 0.03 (0.87)
  I have the skills to ensure my research is translated 1 (14.3) 17 (35.4) 1.24 (0.27)
  There is adequate funding to support translation of my research 0 (0) 1 (2.1) 0.15 (0.70)
  Spending time on research translation would take me away from 
research I enjoy
3 (42.9) 13 (27.1) 0.74 (0.39)
  Researchers with implementation experience/interest should translate 
my research
3 (42.9) 25 (52.1) 0.21 (0.65)
  Every research team should include a researcher with expertise in 
implementation
5 (71.4) 33 (68.8) 0.02 (0.89)
*More than one response could be selected.
†‘Neither agree nor disagree’ pooled with ‘agree’ for response to negative statement.
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discussed research findings being incorporated into clin-
ical guidelines.
[Evidence from clinical trial] is going to … eventually 
be in almost all guidelines around the world, which 
… then is going to influence how people manage ear-
ly rehabilitation [Clinical_3].
Clinical researchers also described translating research 
findings to health policy.
We’ve been able to design it in a way … which will 
take it directly from being within a research project 
pilot environment right through to being adopted 
within the health system as part of policy and practice 
[Clinical_4].
Importance of research translation
Despite all but one of the survey participants reporting 
that research translation was important, seven survey 
participants (n=1, 14% preclinical; n=6, 13% clinical 
researchers) did not disagree with the statement that 
their research could not be translated. Similarly, there 
was some inconsistency between interview participants’ 
opinions regarding whether all research projects needed 
to have translation potential. Two preclinical researchers 
considered that translation was not always important.
Not every project has to have direct translation poten-
tial [Preclinical_3].
In contrast, clinical researchers consistently reported 
considering how their research would be used. The 
importance of considering translation potential at the 
design stage was described:
When you’re setting up a study, how important is it 
going to be and if it’s not going to change clinical 
practice you have to say, should you be doing it? If it’s 
working toward another study that’s going to change 
clinical practice that’s acceptable, but it has to have 
that aim in mind [Clinical_3].
There were divergent views about when research 
translation plans should be organised. Some clinical 
researchers advocated organising research translation 
plans at the commencement of a clinical trial. However, 
the trend towards creating translation plans for clinical 
interventions prior to their efficacy being known was 
raised as a concern by one participant:
I don’t know if [every project having a research trans-
lation plan] is the ideal … It’s a lot of effort to do 
that, and how do we know if something works? … 
Do you start up early and engage these people and 
potentially waste their time? … They’ll say, ‘Well 
what's the evidence for it?’ You say, ‘Well we don’t re-
ally know because we haven’t finished the research’ 
[Clinical_5].
Conducting new research was often a higher priority for 
the research team than coordinating research translation.
[Research] translation needs to be undertaken by 
others otherwise the research team is not going to do 
any more research’ [Clinical_3].
Often … the funding runs out, the papers will get 
written and maybe published but then there’s very lit-
tle [research translation activity], you’re already mov-
ing on to the next thing [Clinical_4].
When synthesising the survey and interview findings, 
it was apparent that research translation was deemed to 
be important by most preclinical and clinical researchers. 
Differing views of how research could be translated 
appeared to influence participants’ perceptions of trans-
lation potential—some preclinical researchers reported 
that discovery research did not have translation poten-
tial, whereas other preclinical and clinical researchers 
reported that exploratory/discovery research could 
direct or refine future research projects. Translation was 
consistently reported to be important for generating 
research impact. Despite its apparent importance, trans-
lating beyond publication was not always a priority for the 
research team, who tended to focus on conducting and 
publishing new research.
Responsibility for research translation
The majority of preclinical (n=4, 57%) and clinical (n=37, 
77%) researchers agreed that it was their own responsi-
bility to translate their research. All interview participants 
expressed the opinion that researchers should dissem-
inate their research findings via academic publications 
and conference presentations. However, differing opin-
ions existed regarding the scope of researchers’ respon-
sibility beyond this initial dissemination; all preclinical 
(n=7, 100%) and most clinical researchers (n=37, 77%) 
reported in the survey that they considered a project 
complete when the findings were published.
In interviews, preclinical and clinical researchers 
described assuming responsibility for translating findings 
to other research contexts by actively seeking collabora-
tions with other researchers.
I’m a big believer in pulling groups of people togeth-
er … because … that way we’re going to get answers 
rather than doing it in our own little separate labs 
and separate research groups [Clinical_2]
There was a consistently held view that researchers had 
a responsibility to conduct relevant research:
As researchers we need to be asking questions that 
the clinicians are asking and the consumers are push-
ing for [Clinical_6].
There were disparate views regarding who should be 
responsible for research-to-practice translation:
I honestly think … because they are leading the 
research … it is the researcher’s responsibility 
[Clinical_7].
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[Research translation] should be a co-responsibil-
ity between the researchers and the clinical setting 
[Clinical_8].
In an ideal world, this is the job for the clinicians 
[Clinical_5].
Many interview participants and clinical researcher 
survey participants (n=32, 67%) reported that clinicians 
should be responsible for research-to-practice transla-
tion. The view that research-to-practice translation was an 
integral part of responsible health professional practice 
was sometimes explicitly stated.
[Clinicians] should be looking at the literature, and 
the key opinion leaders in that area should be…
working out how they can improve their practice 
[Clinical_5].
It’s the responsibility of every … clinician to act in a 
professional manner based upon the evidence avail-
able [Clinical_9].
Responsibility also lay with clinical leaders and managers 
to support and encourage clinicians to translate research.
The top level must have a very firm view about what’s 
going on in the local health district or in the orga-
nization … and send out encouraging signals all the 
time about the necessity of [research translation]’ 
[PreClinical_1].
Other participants reported that while research trans-
lation should be initiated by the research team, respon-
sibility for implementation should be handed over to 
researchers or clinicians with expertise in translation. 
Approximately half of survey respondents (43% preclin-
ical, 52% clinical) reported that researchers with an 
interest in implementation should be responsible for 
translating their research.
It’s the responsibility of the team that does the re-
search to put the translational strategies in place. But 
they’re not going to be able to do it all themselves 
because that’s another whole science, translating it 
properly. But they need to initiate the process and 
that might be to engage a team of people to do it 
[Clinical_3].
I actually do think it’s everyone’s responsibility, but 
that’s not to say I’m going to do implementation … 
I really hope someone else would do it … someone 
who’s trained in implementation [Clinical_10].
Peak organisations such as the Stroke Foundation and 
state clinical and funding bodies were identified as having 
some responsibility for large-scale translation projects.
I think the [state bodies] have got some responsibil-
ity to disseminate the information and look whether 
that is a priority, to look at services … to say okay, well 
[Health Service] has tried this, who wants to put their 
hands up in a larger project to trial it or implement 
it? They’ll give you guidance at the same time … And 
then if it’s bigger than that it would be almost the 
National Stroke Foundation to run it from a national 
level [Clinical_11].
In synthesising data from the survey and interviews, 
preclinical and clinical researchers consistently reported 
having a responsibility to publish and present their results 
to the academic community. Many reported a responsi-
bility to ensure that the research findings would be of 
value to other parties such as researchers, clinicians, 
people with stroke or policy-makers. However, there 
was inconsistency between both preclinical and clinical 
researchers regarding their responsibility to support 
other parties to apply the disseminated findings, which 
may limit translation and subsequent impact of research 
being conducted within CRE-Stroke.
Skills and knowledge
Less than half of the survey respondents reported that 
they had the skills (n=1, 14% preclinical; n=17, 35% clin-
ical) and knowledge (n=3, 43% preclinical; n=19, 40% 
clinical) to translate their research beyond the narrow 
remit of publications and conference presentations:
[Research translation] is not really where my skill sets 
lie [Preclinical_2].
I’m not trained in implementation … that’s not my 
skillset [Clinical_10].
Clinical researchers consistently stressed the difficulty 
and complexity of research-to-practice translation, and 
most felt inadequately skilled to coordinate these activi-
ties. Many interview participants recommended seeking 
input from people with expertise in research-to-prac-
tice translation, which was consistent with the majority 
of survey respondents (n=5, 71% preclinical; n=33, 69% 
clinical) who reported that every research team should 
include a researcher with expertise in implementation:
[Research translation] is such a complex area, it’s a 
little bit naive of me to say I can do that. It needs to 
be the implementation experts involved in that … I 
know enough to know I don’t know enough about 
how you would do an effective translation project 
[Clinical_2].
A lack of common understanding between clinical 
researchers and clinicians was also reported, which could 
make research-to-practice translation difficult:
Researchers and clinicians don’t necessarily under-
stand each other’s world very well. So anything that 
helped clinicians understand the importance of the 
research findings … or that helped researchers un-
derstand what it’s going to be like to try and trans-
late that into a real-world setting … will be useful 
[Clinical_8].
In contrast to the reported difficulties of research-to-
practice translation, researchers’ self-reported lack of 
translation skills did not appear to adversely influence 
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translation of research findings to other research projects. 
Researchers reported that research translation was 
facilitated by the close collaborative networks within 
CRE-Stroke.
In the Australian community … there hasn’t been as 
productive interactions between [neuroscientists and 
the rehabilitation community] as there could have 
been … I think part of [research translation] is to 
move over those historical and cultural and person-
ality-based issues to move forward … to say ‘here’s an 
idea. Could this be relevant? Could this be a value 
add?’ And I think that’s very difficult to do that … 
Every day I’m really happy to be surrounded by the 
network of people in the CRE [Preclinical_2].
Both preclinical and clinical researchers reported that 
the terminology used by different research groups could 
make these discussions more difficult:
There is still a divide between experimental basic 
research and implementation research, and some-
times it is that we’re not speaking the same language 
[Preclinical_4].
Researchers with authorised roles in clinical settings 
reported more confidence in their ability to coordinate 
research-to-practice translation, with one participant 
giving the example:
In a high intensity teaching hospital environment … 
we developed protocols [to implement research find-
ings] … At weekly meetings, if the protocol wasn’t 
adhered to, there would always be questions asked, 
‘Why didn’t you follow the protocol [Clinical_3].
Findings from interviews and surveys indicated that 
preclinical and clinical researchers were frequently 
lacking confidence in research translation skills and 
knowledge. Looking deeper, participants’ knowledge 
and skills were deemed by both groups of researchers to 
be adequate for research-to-research translation, which, 
although challenging, was facilitated by the expectations 
within CRE-Stroke and by pre-existing interdisciplinary 
research networks. Similarly, researchers felt confident to 
coordinate diffusion and dissemination of their findings.
In contrast, the implementation stage of research-to-
practice translation was consistently described as diffi-
cult and complex, and a ‘science in itself’. Apart from 
researchers who had formal positions within health 
services, preclinical and clinical researchers reported a 
lack of confidence regarding their skills and knowledge 
to coordinate implementation of research findings.
DIsCussIOn
In this study, the opinions about research translation held 
by leading Australian stroke rehabilitation researchers 
were obtained. The intricacies of research translation 
within one research community have been highlighted, 
with different descriptions of research translation, 
differing values placed on translation and a lack of clarity 
regarding who should be responsible for research trans-
lation. These findings reflect the emerging thinking 
regarding research translation in the international liter-
ature, where complexity theory14 (making sense of the 
‘mess’ that is the real world in which implementation 
occurs) is being espoused to guide and understand 
research translation, rather than the outdated linear 
‘pipeline’ model.15
While the numbers of clinical researchers outweighed 
preclinical researcher participants in both the survey 
and the interviews, patterns emerged from the opin-
ions of the two groups. Similar themes arose from 
preclinical and clinical researchers when asked to 
describe research translation. Along with the tradi-
tional ‘bench-to-bedside’ translation, both preclinical 
and clinical researchers described translating from 
‘bedside to bench’, where the physiological mecha-
nisms or biomarkers associated with clinical signs and 
symptoms relevant to stroke recovery were investigated. 
The importance of viewing research translation as 
an iterative process, using circular rather than linear 
models has been reported previously16 and is important 
in CRE-Stroke to contribute to a clearer understanding 
of the physiological underpinnings of stroke recovery 
and a better knowledge about which stroke survivors 
are likely to respond to different therapies.
Despite preclinical and clinical researchers frequently 
having different goals from research translation, similar 
views were expressed by the two groups about lacking the 
skills and knowledge to translate research. Researchers 
were particularly lacking confidence with their ability 
to coordinate the implementation phase of research-to-
practice translation and did not always see this as their 
responsibility. Traditionally research-to-practice trans-
lation is initiated by researchers disseminating their 
research results to the target users (clinical teams)4 
who then determine the importance of the research 
and decide whether to attempt implementation.17 
This handover of responsibility for implementation 
can be problematic, with consistent evidence globally 
of evidence-practice gaps4 18–20 and substantial delays 
between dissemination until application in clinical prac-
tice. The phases of research-to-practice translation (ie, 
diffusion, dissemination, implementation) for which 
researchers felt responsible were varied and numerous 
parties were nominated as having responsibility for 
implementation. Our findings reflect the discord in 
the international literature, where responsibility for 
research translation has been attributed to researchers,4 
clinical teams,21 shared between researchers and 
funding agencies22 or between researchers and clinical 
teams.5 It is recognised that having a one-size-fits-all 
approach to all research-to-practice translation proj-
ects is impractical.23 Further, it is important to acknowl-
edge the specialised and discrete skills required for 
conducting research versus research-to-practice transla-
tion.23 The party(s) responsible for research-to-practice 
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translation must have buy-in and credibility with the 
end-users,23 24 which might recommend particular indi-
viduals to coordinate particular projects regardless of 
their research or clinical background. The opinions of 
non-researcher clinicians were not sought in this study. 
However, the difficulties clinicians face to stay abreast 
of the ever-expanding body of research knowledge are 
well-documented,25 26 making the delegation of full 
responsibility for translation of disseminated results to 
clinical teams impractical.
The point at which research is deemed to have been 
‘translated successfully’ requires clarification. The 
explicit research translation requirements from most 
international funders of health research are that results 
and summaries for lay people are published.22 There-
fore, funders are supporting the premise that transla-
tion is complete when results are disseminated. While 
impact is a new metric being introduced into Australia’s 
Excellence in Research Assessment from 2018 to eval-
uate university research performance,1 it forms a small 
component of the assessment which is heavily weighted 
towards publications’ citations. Similarly, in the UK’s 
Research Excellence Framework, impact forms only 
25% of the assessment.2 Currently in Australia, there 
is no dedicated funding source to support implemen-
tation of positive research findings, which prevented 
some interview participants from overseeing their 
desired research-to-practice translation activities. 
Further, no group has a clear mandate to coordinate 
implementation, so no party is adequately incentivised, 
supported or held accountable to ensure that patients 
receive appropriate evidence-based care.
Findings from this study will inform strategies to support 
research translation and impact for CRE-Stroke. First, a 
series of education and skills development workshops has 
been organised to address the reported needs of both 
preclinical and clinical researchers regarding research 
translation. Second, clinical stipends have been granted 
to support small-scale collaborative projects between 
CRE-Stroke researchers and clinicians to build research 
capacity, build capacity for research-to-practice trans-
lation and to enhance researcher–clinician networks. 
Third, in an embedded validation study (described in full 
elsewhere),27 the Framework to Assess the Impact from 
Translational health research3 will be applied to work-
streams within CRE-Stroke to encourage research transla-
tion and assess research impact. Ongoing discussions will 
be held with key stakeholders to highlight the uncertain-
ties regarding responsibility for implementation of posi-
tive clinical research findings.
This study is unique because participants were 
conducting research across the spectrum from basic 
science to population health. Data were collected within 
a stroke rehabilitation research community, but the 
findings are relevant to other areas of health research, 
conducted within similar institutions and funded by 
similar agencies. Having EAL and SAR (both CRE-Stroke 
postdoctoral researchers within their first 6 months of 
affiliation with the CRE) conduct the interviews may have 
influenced participants’ responses about research transla-
tion to be more favourable given that research translation 
is a cross-cutting theme of CRE-Stroke. Conversely, partic-
ipants may have been more likely to identify barriers to 
translation, given the two interviewers understood the 
complexity and context of research translation within 
CRE-Stroke and had framed the interviews as a means 
to inform the development of strategies to enhance 
future research translation and impact. All participants 
were informed that only EAL and SAR had access to the 
raw data. EAL was based at a separate university from all 
participants, and SAR had not had prior contact with the 
majority of participants prior to the interviews. A limita-
tion of the data and subsequent analysis is that most survey 
and interview participants were clinical researchers, 
reflecting the profile of CRE-Stroke researchers and 
affiliates.
COnClusIOn
It is promising that the majority of preclinical and clin-
ical researchers recognise the importance of research 
translation and feel confident to translate their research 
findings to other research projects. However, the lines 
of responsibility to ensure research findings are trans-
lated to clinical practice and policy need to be clarified 
to maximise impact and to allow responsible parties to 
be supported with appropriate resources and training.
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